14 results
20-F
2021 FY
VALN
Valneva SE
24 Mar 22
Annual report (foreign)
12:32pm
to identify or access. This may be due in part to reputational challenges that the vaccine industry is facing related to the growing momentum of the anti … vaccines and therapies;
the existence of alternative therapies;
the public perception of new therapies and the reputational challenges that the vaccine
424B4
VALN
Valneva SE
1 Nov 21
Prospectus supplement with pricing info
4:06pm
. This may be due in part to reputational challenges that the vaccine industry is facing related to the growing momentum of the anti-vaccine movement … to alternative vaccines and therapies;
the existence of alternative therapies;
the public perception of new therapies and the reputational challenges
F-1
VALN
Valneva SE
26 Oct 21
Registration statement (foreign)
5:04pm
or access. This may be due in part to reputational challenges that the vaccine industry is facing related to the growing momentum of the anti-vaccine movement … to alternative vaccines and therapies;
the existence of alternative therapies;
the public perception of new therapies and the reputational
DRS
l8l89d7rnd4hbop2
20 Oct 21
Draft registration statement
12:00am
424B4
1ba 64ong5yl
7 May 21
Prospectus supplement with pricing info
4:06pm
F-1/A
ljwpgy8xz l089gx
5 May 21
Registration statement (foreign) (amended)
6:07am
F-1/A
wp1w7sz9fd ysemn1d
29 Apr 21
Registration statement (foreign) (amended)
6:08am
F-1/A
pbbwe nlf
21 Apr 21
Registration statement (foreign) (amended)
5:06pm
F-1
c1f7zlp12p k58n
9 Apr 21
Registration statement (foreign)
4:06pm
DRS/A
s6y0au
24 Mar 21
Draft registration statement (amended)
12:00am
DRS/A
htj5igu
24 Feb 21
Draft registration statement (amended)
12:00am
DRS
1zy8 10nfxqsq
15 Jan 21
Draft registration statement
12:00am
- Prev
- 1
- Next